Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc
The global Nitinol-based Interventional Device market was valued at US$ 21890 million in 2023 and is anticipated to reach US$ 36460 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The Nitinol-based Interventional Device market is driven by the growing demand for minimally invasive medical procedures and the unique properties of Nitinol alloy in interventional device design. Nitinol, a shape memory alloy, offers remarkable flexibility, shape retention, and biocompatibility, making it an ideal material for various interventional devices like stents, guidewires, and filters. The rise in chronic diseases, such as cardiovascular conditions and peripheral artery diseases, contributes to market growth as healthcare professionals seek advanced devices that ensure precise placement and effective treatment. Moreover, Nitinol's ability to change shape with temperature variations aligns with improved device deployment and reduced patient discomfort. However, the market also faces challenges, including manufacturing complexities due to the unique properties of Nitinol and the need for rigorous testing to ensure device reliability. Additionally, addressing concerns related to long-term device performance and biocompatibility, and managing potential allergic reactions, can pose obstacles for manufacturers. To succeed, companies must focus on material advancements, precise device engineering, and addressing the challenges to provide safe and efficient Nitinol-based interventional devices that enhance patient outcomes and revolutionize minimally invasive medical procedures.
This report aims to provide a comprehensive presentation of the global market for Nitinol-based Interventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol-based Interventional Device.
Report Scope
The Nitinol-based Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nitinol-based Interventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nitinol-based Interventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Segment by Type
Stents
Guidewires
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nitinol-based Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nitinol-based Interventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Nitinol-based Interventional Device Market Overview
1.1 Product Overview and Scope of Nitinol-based Interventional Device
1.2 Nitinol-based Interventional Device Segment by Type
1.2.1 Global Nitinol-based Interventional Device Market Value Comparison by Type (2024-2030)
1.2.2 Stents
1.2.3 Guidewires
1.2.4 Others
1.3 Nitinol-based Interventional Device Segment by Application
1.3.1 Global Nitinol-based Interventional Device Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nitinol-based Interventional Device Market Size Estimates and Forecasts
1.4.1 Global Nitinol-based Interventional Device Revenue 2019-2030
1.4.2 Global Nitinol-based Interventional Device Sales 2019-2030
1.4.3 Global Nitinol-based Interventional Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nitinol-based Interventional Device Market Competition by Manufacturers
2.1 Global Nitinol-based Interventional Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nitinol-based Interventional Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nitinol-based Interventional Device Average Price by Manufacturers (2019-2024)
2.4 Global Nitinol-based Interventional Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nitinol-based Interventional Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitinol-based Interventional Device, Product Type & Application
2.7 Nitinol-based Interventional Device Market Competitive Situation and Trends
2.7.1 Nitinol-based Interventional Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nitinol-based Interventional Device Players Market Share by Revenue
2.7.3 Global Nitinol-based Interventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nitinol-based Interventional Device Retrospective Market Scenario by Region
3.1 Global Nitinol-based Interventional Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nitinol-based Interventional Device Global Nitinol-based Interventional Device Sales by Region: 2019-2030
3.2.1 Global Nitinol-based Interventional Device Sales by Region: 2019-2024
3.2.2 Global Nitinol-based Interventional Device Sales by Region: 2025-2030
3.3 Global Nitinol-based Interventional Device Global Nitinol-based Interventional Device Revenue by Region: 2019-2030
3.3.1 Global Nitinol-based Interventional Device Revenue by Region: 2019-2024
3.3.2 Global Nitinol-based Interventional Device Revenue by Region: 2025-2030
3.4 North America Nitinol-based Interventional Device Market Facts & Figures by Country
3.4.1 North America Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nitinol-based Interventional Device Sales by Country (2019-2030)
3.4.3 North America Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nitinol-based Interventional Device Market Facts & Figures by Country
3.5.1 Europe Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nitinol-based Interventional Device Sales by Country (2019-2030)
3.5.3 Europe Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol-based Interventional Device Market Facts & Figures by Country
3.6.1 Asia Pacific Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nitinol-based Interventional Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nitinol-based Interventional Device Market Facts & Figures by Country
3.7.1 Latin America Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nitinol-based Interventional Device Sales by Country (2019-2030)
3.7.3 Latin America Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nitinol-based Interventional Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol-based Interventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nitinol-based Interventional Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nitinol-based Interventional Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nitinol-based Interventional Device Sales by Type (2019-2030)
4.1.1 Global Nitinol-based Interventional Device Sales by Type (2019-2024)
4.1.2 Global Nitinol-based Interventional Device Sales by Type (2025-2030)
4.1.3 Global Nitinol-based Interventional Device Sales Market Share by Type (2019-2030)
4.2 Global Nitinol-based Interventional Device Revenue by Type (2019-2030)
4.2.1 Global Nitinol-based Interventional Device Revenue by Type (2019-2024)
4.2.2 Global Nitinol-based Interventional Device Revenue by Type (2025-2030)
4.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Type (2019-2030)
4.3 Global Nitinol-based Interventional Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nitinol-based Interventional Device Sales by Application (2019-2030)
5.1.1 Global Nitinol-based Interventional Device Sales by Application (2019-2024)
5.1.2 Global Nitinol-based Interventional Device Sales by Application (2025-2030)
5.1.3 Global Nitinol-based Interventional Device Sales Market Share by Application (2019-2030)
5.2 Global Nitinol-based Interventional Device Revenue by Application (2019-2030)
5.2.1 Global Nitinol-based Interventional Device Revenue by Application (2019-2024)
5.2.2 Global Nitinol-based Interventional Device Revenue by Application (2025-2030)
5.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Application (2019-2030)
5.3 Global Nitinol-based Interventional Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Nitinol-based Interventional Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Corporation Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Edwards Lifesciences Nitinol-based Interventional Device Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Nitinol-based Interventional Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Nitinol-based Interventional Device Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 TERUMO
6.5.1 TERUMO Corporation Information
6.5.2 TERUMO Description and Business Overview
6.5.3 TERUMO Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TERUMO Nitinol-based Interventional Device Product Portfolio
6.5.5 TERUMO Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Nitinol-based Interventional Device Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stryker Nitinol-based Interventional Device Product Portfolio
6.7.5 Stryker Recent Developments/Updates
6.8 Cook Medical
6.8.1 Cook Medical Corporation Information
6.8.2 Cook Medical Description and Business Overview
6.8.3 Cook Medical Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cook Medical Nitinol-based Interventional Device Product Portfolio
6.8.5 Cook Medical Recent Developments/Updates
6.9 Cordis
6.9.1 Cordis Corporation Information
6.9.2 Cordis Description and Business Overview
6.9.3 Cordis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cordis Nitinol-based Interventional Device Product Portfolio
6.9.5 Cordis Recent Developments/Updates
6.10 B. Braun
6.10.1 B. Braun Corporation Information
6.10.2 B. Braun Description and Business Overview
6.10.3 B. Braun Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 B. Braun Nitinol-based Interventional Device Product Portfolio
6.10.5 B. Braun Recent Developments/Updates
6.11 Biotronik
6.11.1 Biotronik Corporation Information
6.11.2 Biotronik Nitinol-based Interventional Device Description and Business Overview
6.11.3 Biotronik Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biotronik Nitinol-based Interventional Device Product Portfolio
6.11.5 Biotronik Recent Developments/Updates
6.12 MicroPort
6.12.1 MicroPort Corporation Information
6.12.2 MicroPort Nitinol-based Interventional Device Description and Business Overview
6.12.3 MicroPort Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Nitinol-based Interventional Device Product Portfolio
6.12.5 MicroPort Recent Developments/Updates
6.13 JOTEC
6.13.1 JOTEC Corporation Information
6.13.2 JOTEC Nitinol-based Interventional Device Description and Business Overview
6.13.3 JOTEC Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 JOTEC Nitinol-based Interventional Device Product Portfolio
6.13.5 JOTEC Recent Developments/Updates
6.14 Acandis
6.14.1 Acandis Corporation Information
6.14.2 Acandis Nitinol-based Interventional Device Description and Business Overview
6.14.3 Acandis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Acandis Nitinol-based Interventional Device Product Portfolio
6.14.5 Acandis Recent Developments/Updates
6.15 ELLA-CS
6.15.1 ELLA-CS Corporation Information
6.15.2 ELLA-CS Nitinol-based Interventional Device Description and Business Overview
6.15.3 ELLA-CS Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ELLA-CS Nitinol-based Interventional Device Product Portfolio
6.15.5 ELLA-CS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol-based Interventional Device Industry Chain Analysis
7.2 Nitinol-based Interventional Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol-based Interventional Device Production Mode & Process
7.4 Nitinol-based Interventional Device Sales and Marketing
7.4.1 Nitinol-based Interventional Device Sales Channels
7.4.2 Nitinol-based Interventional Device Distributors
7.5 Nitinol-based Interventional Device Customers
8 Nitinol-based Interventional Device Market Dynamics
8.1 Nitinol-based Interventional Device Industry Trends
8.2 Nitinol-based Interventional Device Market Drivers
8.3 Nitinol-based Interventional Device Market Challenges
8.4 Nitinol-based Interventional Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
听
听
*If Applicable.
